It is not the active ingredient in any FDA-approved drug product, and there is no United States Pharmacopeia (USP) monograph for either AOD-9604 (free base) or AOD-9604 acetate
pluripotency expands application scope beyond mesodermal tissues
Despite the availability of recombinant erythropoietin and the more liberal use of intravenous iron dextran in recent years, a large proportion of maintenance dialysis patients continue to suffer from anemia or require large doses of erythropoietin to maintain blood hemoglobin concentrations within the recommended range
In vitro studies have demonstrated that BPC-157 stimulates the expression of vascular endothelial growth factor (VEGF) and fibroblast growth factor (FGF)
How body weight affects the maintenance dose People with higher starting weights may need to reach the higher doses (12.5 mg or 15 mg) to see maximum results
Conversely, residues within positions 4552, except for residue 49, did not exhibit a notable increase in the hetNOE value